Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market By Product Type (Endoscopes, Endotherapy Devices,Visualization Systems), By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation), And By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Other End Users) - Forecast Year 2024 – 2031
Healthcare // Medical Devices
The global Endoscopic
Retrograde Cholangiopancreatography (ERCP) market is foreseen to grow at 8.1%,
from USD 1.35 Billion in 2021 to USD 2.54 Billion in 2029. Rising incidence of
cancer, increasing investments, funds, and grants by governments and healthcare
organizations to improve endoscopy research, growing focus on investments by
hospitals for advanced endoscopy instruments are the factors to grow the global
endoscopic retrograde cholangiopancreatography (ERCP) market. However, high
costs of endoscopic retrograde cholangiopancreatography devices, development of
other procedures like EUS and MRCP is seen restraint the market growth for the
estimated period.
Market Definition
What is Endoscopic
Retrograde Cholangiopancreatography (ERCP)?
Endoscopic
retrograde cholangiopancreatography (ERCP) is a procedure to diagnose and treat
problems in the pancreas, liver, bile ducts, and gallbladder. It is a combination
of X-ray and the upper gastrointestinal (GI) endoscope used for the diagnosis of
such problems.
Market Overview
The
endoscopic retrograde cholangiopancreatography (ERCP) market search
study helps to thoroughly understand the current trend in the market
competitive analysis of the players in the emerging market. Moreover, the DRO
in the endoscopic retrograde cholangiopancreatography (ERCP) market offers
valuable perspicuity and a current scenario for making the right decision. The
research study covers the eminent players in the market with a detailed
analysis of the company and a financial overview containing their net sales,
business mix and geographical reach It mainly focuses on the key developments
of the products/services offered by the company in recent years. Besides, we at
Zettabyte have the expertise to analyses the global endoscopic retrograde
cholangiopancreatography (ERCP) market player's competitive landscape helping
the client comprehend their specific strategic growth approaches.
Endoscopic
retrograde cholangiopancreatography (ERCP) market study by "Zettabyte
Analytics" offers details about the market scope, market segmentation,
technological advancement in the Endoscopic retrograde cholangiopancreatography
(ERCP) market and highlights the optimistic, competitive landscape and trends
enduring over the years.
Major players in
the endoscopic retrograde cholangiopancreatography (ERCP) market Ambu A/S, B.
Braun Melsungen AG, Boston Scientific Corporation, Changzhou Health Microport
ME, Conmed Corporation, Cook Medical, Fujifilm Holdings Corporation, Hobbs
Medical, Inc., Hoya Corporation, Huger Medical Instrument Co., Intromedic Co.,
Ltd., Johnson & Johnson,Karl Storz Se & Co. KG, Medi-Globe GmbH,
Medtronic, Plc, Merit Medical Systems, Inc., Olympus Corporation, Sonoscape
Medical Corp., Steris Plc, Taewoong Medical Co., Ltd., Telemed Systems, Inc.
COVID-19 Impact on Global Endoscopic
retrograde cholangiopancreatography (ERCP) market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. The impact of COVID-19 on the endoscopic retrograde
cholangiopancreatography (ERCP) market has forced the companies to change their
sourcing, pricing, and promotion strategies. The endoscopic retrograde
cholangiopancreatography (ERCP) market players are seen focusing more on
optimizing the E-commerce networks with the rising innovations in the digital
sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). The market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and endoscopic retrograde
cholangiopancreatography (ERCP) market future markets are analyzed to
understand their impact on demand for the forecast period. Growth rates have
been estimated using correlation, regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global endoscopic retrograde cholangiopancreatography
(ERCP) market segmented on the basis of product type, procedure, end user and
region:
Product Type Outlook:
On the basis of
product type, the market is segmented into endoscopes, endotherapy devices,
energy devices, visualization systems, others.
Figure 1 Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market By Product Type (Market Size And
Forecast By Value - USD Million, 2021 & 2029)
Procedure Outlook:
On the basis of
procedure, the market is segmented into biliary dialtation, biliary
sphincterotomy, biliary stenting, pancreatic duct dilatation, pancreatic duct
stenting, pancreatic sphincterotomy.
Figure 2 Procedure Outlook (Revenue, USD
Million, 2021)
End User Outlook:
On the basis of
end user, the market is segmented into ambulatory surgery centres &
clinics, hospitals, other end users.
Figure 3 End User Outlook (Revenue, USD
Million, 2021)
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 4 Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market: Regional dynamics
An exclusive endoscopic retrograde cholangiopancreatography (ERCP)
market research report provides an in-depth analysis of the market dynamics
across five regions: North America, Europe, South America, Asia-Pacific, Middle
East, and Africa. Furthermore, the market has been evaluated by utilizing
diverse research methodologies and internal statistical models.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. some of the prominent players in the endoscopic
retrograde cholangiopancreatography (ERCP) market include
· Ambu A/S
· B. Braun Melsungen
AG
· Boston Scientific
Corporation
· Changzhou Health
Microport ME
· Conmed Corporation
· Cook Medical
· Fujifilm Holdings
Corporation
· Hobbs Medical, Inc.
· Hoya Corporation
· Huger Medical
Instrument Co.,
· Intromedic Co.,
Ltd.
· Johnson &
Johnson
· Karl Storz Se &
Co. KG
· Medi-Globe GmbH
· Medtronic, Plc
· Merit Medical
Systems, Inc.
· Olympus Corporation
· Sonoscape Medical
Corp.
· Steris Plc
· Taewoong Medical
Co., Ltd.
· Telemed Systems,
Inc.
Global Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market Report Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2029 |
2.52 Billion |
|
Growth
Rate |
CAGR of 8.1%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product type, Procedure, End User. |
|
Key
companies profiled |
Ambu A/S, B.
Braun Melsungen AG, Boston Scientific Corporation, Changzhou Health Microport
ME |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Endoscopes
· Endotherapy Devices
· Energy Devices
· Visualization
Systems
· Others
o Balloons
o Baskets
o Cannulas
o Catheters
o Forceps
o Guiding Wires
o Lithotripter
o Snares
o Sphincterotomes
o Stents
Procedure Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Biliary Dialtation
· Biliary
Sphincterotomy
· Biliary Stenting
· Pancreatic Duct
Dilatation
· Pancreatic Duct
Stenting
· Pancreatic
Sphincterotomy
End User Outlook (Revenue, USD Million/Billion;
2018-2029)
· Ambulatory Surgery
Centres & Clinics
· Hospitals
· Other End Users
Regional Outlook (Revenue, USD
Million/Billion; 2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Reasons to Buy the Report:
· Save and reduce
time carrying out entry-level research by identifying the growth, size, leading
players and segments in the global endoscopic retrograde
cholangiopancreatography (ERCP) market
· Highlights key
business priorities in order to guide the companies to reform their business
strategies and establish themselves in the wide geography.
· The key findings
and recommendations highlight crucial progressive industry trends in the endoscopic
retrograde cholangiopancreatography (ERCP) market, thereby allowing players to
develop effective long-term strategies in order to garner their market revenue.
· Develop/modify
business expansion plans by using substantial growth offering developed and
emerging markets.
· Scrutinize in-depth
global market trends and outlook coupled with the factors driving the market,
as well as those restraining the growth at a certain extent.
· Enhance the
decision-making process by understanding the strategies that underpin
commercial interest with respect to products, segmentation and industry
verticals.
|
Chapter 1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for Study |
|
|
Chapter 2. Research Methodology |
|
|
2.1. Research Sources |
|
|
2.1.1. Primary |
|
|
2.1.2. Secondary |
|
|
2.2. Market Size Estimation |
|
|
Chapter 3. Executive Summary |
|
|
3.1. Summary Snapshot Market Size and Forecast, 2018-2029 |
|
|
3.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Share by Product Type, 2021 vs 2029 (USD Million) |
|
|
3.3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Share by Procedure, 2021 vs 2029 (USD Million) |
|
|
3.4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Share by End User, 2021 vs 2029 (USD Million) |
|
|
3.5. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Share by Company, 2021 vs 2029 (USD Million) |
|
|
3.6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Share by Region, 2021 vs 2029 (USD Million) |
|
|
Chapter 4. Key Insights |
|
|
Chapter 5. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market Segmentation & Impact Analysis |
|
|
5.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
Indicators Analysis |
|
|
5.1.1. Market Drivers Analysis |
|
|
5.1.1.1. Growing
focus on investments by hospitals for advanced endoscopy instruments |
|
|
5.1.1.2. Increasing
investments, funds, and grants by governments and healthcare organizations to
improve endoscopy research |
|
|
5.1.1.3. Increasing
preference for minimally invasive surgeries |
|
|
5.1.1.4. Rising incidence of cancer |
|
|
5.1.2. Market Restraint Analysis |
|
|
5.1.2.1. High costs
of endoscopic retrograde cholangiopancreatography devices |
|
|
5.1.2.2. Development
of other procedures like EUS and MRCP |
|
|
5.1.3. Market Opportunity Analysis |
|
|
5.1.3.1. The growing
healthcare sector in emerging economies |
|
|
5.1.3.2. Increasing
adoption of single-use endoscopy instruments |
|
|
5.2. Regulatory Analysis |
|
|
5.2.1. North America |
|
|
5.2.1.1. U.S. |
|
|
5.2.1.2. Canada |
|
|
5.2.2. Europe |
|
|
5.2.2. Asia Pacific |
|
|
5.2.2.1. India |
|
|
5.2.2.2. Japan |
|
|
5.2.2.3. China |
|
|
5.3. Technological Insights |
|
|
5.4. COVID-19 Impact analysis on Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market |
|
|
5.5. Porter’s Five Forces Analysis |
|
|
5.5.1. Bargaining Power of Buyers/Consumers |
|
|
5.5.2. Bargaining Power of Suppliers |
|
|
5.5.3. Threat of New Entrants |
|
|
5.5.4. Threat of Substitute Products |
|
|
5.5.5. Intensity of Competitive Rivalry |
|
|
5.6. Competitive Metric Space Analysis |
|
|
Chapter 6. Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
6.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
|
6.1.1. Endoscopes |
|
|
6.1.1.1. Endoscopes Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
6.1.1.2. Endoscopes Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
6.1.2. Endotherapy Devices |
|
|
6.1.2.1. Endotherapy
Devices Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.2. Endotherapy
Devices Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.2.3. Balloons |
|
|
6.1.2.3.1. Balloons Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.3.2. Balloons Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.4. Baskets |
|
|
6.1.2.4.1. Baskets Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.4.2. Baskets Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
6.1.2.5. Cannulas |
|
|
6.1.2.5.1. Cannulas Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.5.2. Cannulas Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.6. Catheters |
|
|
6.1.2.6.1. Catheters Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.6.2. Catheters Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.7. Forceps |
|
|
6.1.2.7.1. Forceps Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.7.2. Forceps Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.2.8. Guiding Wires |
|
|
6.1.2.8.1. Guiding Wires Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.8.2. Guiding Wires Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.9. Lithotripter |
|
|
6.1.2.9.1. Lithotripter Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.9.2. Lithotripter Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.10. Snares |
|
|
6.1.2.10.1. Snares Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.10.2. Snares Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
6.1.2.11.
Sphincterotomes |
|
|
6.1.2.11.1. Sphincterotomes Market Estimates and Forecast, 2019-2029
(USD Million) |
|
|
6.1.2.11.2. Sphincterotomes Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
|
6.1.2.12. Stents |
|
|
6.1.2.12.1. Stents Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.2.12.2. Stents Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
6.1.3. Energy Devices |
|
|
6.1.3.1. Energy
Devices Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.3.2. Energy
Devices Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.4. Visualization Systems |
|
|
6.1.4.1.
Visualization Systems Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.2.
Visualization Systems Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
|
6.1.5. Others |
|
|
6.1.5.1. Others
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.2. Others
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 7. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure (Market Size and
Forecast by Value - USD Million, 2018 - 2029) |
|
|
7.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
7.1.1. Biliary Dialtation |
|
|
7.1.1.1. Biliary Dialtation Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.1.2. Biliary Dialtation Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.2. Biliary Sphincterotomy |
|
|
7.1.2.1. Biliary Sphincterotomy Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
7.1.2.2. Biliary Sphincterotomy Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.3. Biliary Stenting |
|
|
7.1.3.1. Biliary Stenting Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.3.2. Biliary
Stenting Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.4. Pancreatic Duct Dilatation |
|
|
7.1.4.1. Pancreatic
Duct Dilatation Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.4.2. Pancreatic
Duct Dilatation Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.5. Pancreatic Duct Stenting |
|
|
7.1.5.1. Pancreatic
Duct Stenting Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.5.2. Pancreatic
Duct Stenting Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.6. Pancreatic Sphincterotomy |
|
|
7.1.6.1. Pancreatic
Sphincterotomy Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.6.2. Pancreatic
Sphincterotomy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
Chapter 8. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User (Market Size and Forecast
by Value - USD Million, 2018 - 2029) |
|
|
8.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
End User (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
8.1.1. Ambulatory Surgery Centres & Clinics |
|
|
8.1.1.1. Ambulatory Surgery Centres & Clinics
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.1.2. Ambulatory Surgery Centres & Clinics
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
8.1.2. Hospitals |
|
|
8.1.2.1. Hospitals Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
8.1.2.2. Hospitals Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
8.1.3. Other End Users |
|
|
8.1.3.1. Other End
Users Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
8.1.3.2. Other End
Users Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 9. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Region (Market Size and Forecast
by Value - USD Million, 2018 - 2029) |
|
|
9.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Region (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
9.2. North America |
|
|
9.2.1. North America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.2. North America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.2.3. North America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
|
9.2.4. North America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Country, 2018-2029 (USD Million) |
|
|
9.2.5. U.S. |
|
|
9.2.5.1. U.S.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.2.5.2. U.S.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.2.5.3. U.S.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.2.6. Canada |
|
|
9.2.6.1. Canada
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.2.6.2. Canada
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.2.6.3. Canada
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.3. Europe |
|
|
9.3.1. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP)
Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.2. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP)
Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.3.3. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP)
Market, By End User, 2018-2029 (USD Million) |
|
|
9.3.4. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP)
Market, By Country, 2018-2029 (USD Million) |
|
|
9.3.5. Germany |
|
|
9.3.5.1. Germany
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.3.5.2. Germany
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.3.5.3. Germany
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.3.6. U.K. |
|
|
9.3.6.1. U.K.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.3.6.2. U.K.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.3.6.3. U.K.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.3.7. France |
|
|
9.3.7.1. France
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2017-2029 (USD Million) |
|
|
9.3.7.2. France
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2017-2029 (USD Million) |
|
|
9.3.7.3. France
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2017-2029 (USD Million) |
|
|
9.3.8. Spain |
|
|
9.3.8.1. Spain
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.3.8.2. Spain
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.3.8.3. Spain
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.3.9. Italy |
|
|
9.3.9.1. Italy
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.3.9.2. Italy
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.3.9.3. Italy
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.3.10. Rest of Europe |
|
|
9.3.10.1. Rest of
Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.3.10.2. Rest of
Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.3.10.3. Rest of
Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End
User, 2018-2029 (USD Million) |
|
|
9.4.
Asia Pacific |
|
|
9.4.1. Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.2. Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.4.3. Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
|
9.4.4. Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Country, 2018-2029 (USD Million) |
|
|
9.4.5. India |
|
|
9.4.5.1. India
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.4.5.2. India
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.4.5.3. India
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.4.6. Japan |
|
|
9.4.6.1. Japan
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.4.6.2. Japan
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.4.6.3. Japan
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.4.7. China |
|
|
9.4.7.1. China
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2017-2029 (USD Million) |
|
|
9.4.7.2. China
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2017-2029 (USD Million) |
|
|
9.4.7.3. China
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2017-2029 (USD Million) |
|
|
8.4.8. South Korea |
|
|
8.4.8.1. South
Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2028 (USD Million) |
|
|
8.4.8.2. South
Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2028 (USD Million) |
|
|
8.4.8.3. South
Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End
User, 2018-2028 (USD Million) |
|
|
9.4.9. Australia |
|
|
9.4.9.1.
Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.4.9.2.
Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.4.9.3.
Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
End User, 2018-2029 (USD Million) |
|
|
9.4.10. Rest of Asia Pacific |
|
|
9.4.10.1. Rest of Asia Pacific
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.4.10.2. Rest of
Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.4.10.3. Rest of
Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
End User, 2018-2029 (USD Million) |
|
|
9.5. Middle East & Africa |
|
|
9.5.1. Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
|
9.5.2. Middle East & AfricaEndoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.5.3. Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
|
9.5.4. Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Country, 2018-2029 (USD Million) |
|
|
9.5.5. UAE |
|
|
9.5.5.1. UAE
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.5.5.2. UAE
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.5.5.3. UAE
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.5.6. Saudi Arabia |
|
|
9.5.6.1. Saudi
Arabia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.5.6.2. Saudi
Arabia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.5.6.3. Saudi
Arabia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End
User, 2018-2029 (USD Million) |
|
|
9.5.7. South Africa |
|
|
9.5.7.1. South
Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.5.7.2. South
Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.5.7.3. South
Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End
User, 2018-2029 (USD Million) |
|
|
9.5.8. Rest of Middle East & Africa |
|
|
9.5.8.1. Rest of
Middle East & Africa Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.5.8.2. Rest of
Middle East & Africa Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.5.8.3. Rest of
Middle East & Africa Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
|
9.6. Latin America |
|
|
9.6.1. Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.2. Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
|
9.6.3. Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
|
9.6.4. Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Country, 2018-2029 (USD Million) |
|
|
9.6.5. Brazil |
|
|
9.6.5.1. Brazil
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.6.5.2. Brazil
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.6.5.3. Brazil
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End User,
2018-2029 (USD Million) |
|
|
9.6.6. Mexico |
|
|
9.6.6.1. Mexico
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product
Type, 2018-2029 (USD Million) |
|
|
9.6.6.2. Mexico
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Procedure,
2018-2029 (USD Million) |
|
|
9.6.6.3.
Mexico Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By End
User, 2018-2029 (USD Million) |
|
|
9.6.7. Argentina |
|
|
9.6.7.1.
Argentina Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.6.7.2.
Argentina Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
Procedure, 2018-2029 (USD Million) |
|
|
9.6.7.3.
Argentina Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By
End User, 2018-2029 (USD Million) |
|
|
9.6.8. Rest of Latin America |
|
|
9.6.8.1. Rest of
Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market,
By Product Type, 2018-2029 (USD Million) |
|
|
9.6.8.2. Rest of
Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market,
By Procedure, 2018-2029 (USD Million) |
|
|
9.6.8.3. Rest of
Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market,
By End User, 2018-2029 (USD Million) |
|
|
Chapter 10. Competitive Landscape |
|
|
10.1. Market Revenue Share by Manufacturers |
|
|
10.2. Competitor’s Positioning |
|
|
10.3. Strategy Benchmarking |
|
|
10.3.1. Partnership & Agreement |
|
|
10.3.2. New Product Development |
|
|
10.3.3. Mergers & Acquisitions |
|
|
10.3.4. Investment & Expansion |
|
|
10.4. Vendor Landscape |
|
|
10.4.1. Distributors |
|
|
10.4.2. North America |
|
|
10.4.3. Europe |
|
|
10.4.4. Asia Pacific |
|
|
10.4.5. Middle East & Africa |
|
|
10.4.6. Latin America |
|
|
10.5. Zettabyte Analytics Insights for Competitive Landscape |
|
|
Chapter 11. Company Profiles |
|
|
11.1. Ambu A/S |
|
|
11.1.1. Company Overview |
|
|
11.1.2. Products Offered |
|
|
11.1.3. Financials |
|
|
11.1.4. Recent Development |
|
|
11.2. B. Braun Melsungen AG |
|
|
11.2.1. Company Overview |
|
|
11.2.2. Products Offered |
|
|
11.2.3. Financials |
|
|
11.2.4. Recent Development |
|
|
11.3. Boston Scientific Corporation |
|
|
11.3.1. Company Overview |
|
|
11.3.2. Products Offered |
|
|
11.3.3. Financials |
|
|
11.3.4. Recent Development |
|
|
11.4. Changzhou Health Microport ME |
|
|
11.4.1. Company Overview |
|
|
11.4.2. Products Offered |
|
|
11.4.3. Financials |
|
|
11.4.4. Recent Development |
|
|
11.5. Conmed Corporation |
|
|
11.5.1. Company Overview |
|
|
11.5.2. Products Offered |
|
|
11.5.3. Financials |
|
|
11.5.4. Recent Development |
|
|
11.6. Cook Medical |
|
|
11.6.1. Company Overview |
|
|
11.6.2. Products Offered |
|
|
11.6.3. Financials |
|
|
11.6.4. Recent Development |
|
|
11.7. Fujifilm Holdings Corporation |
|
|
11.7.1. Company Overview |
|
|
11.7.2. Products Offered |
|
|
11.7.3. Financials |
|
|
11.7.4. Recent Development |
|
|
11.8. Hobbs Medical, Inc. |
|
|
11.8.1. Company Overview |
|
|
11.8.2. Products Offered |
|
|
11.8.3. Financials |
|
|
11.8.4. Recent Development |
|
|
11.9. Hoya Corporation |
|
|
11.9.1. Company Overview |
|
|
11.9.2. Products Offered |
|
|
11.9.3. Financials |
|
|
11.9.4. Recent Development |
|
|
11.10. Huger Medical Instrument Co., |
|
|
11.10.1. Company Overview |
|
|
11.10.2. Products Offered |
|
|
11.10.3. Financials |
|
|
11.10.4. Recent Development |
|
|
11.11. Intromedic Co., Ltd. |
|
|
11.11.1. Company Overview |
|
|
11.11.2. Products Offered |
|
|
11.11.3. Financials |
|
|
11.11.4. Recent Development |
|
|
11.12. Johnson & Johnson |
|
|
11.12.1. Company Overview |
|
|
11.12.2. Products Offered |
|
|
11.12.3. Financials |
|
|
11.12.4. Recent Development |
|
|
11.13. Karl Storz Se & Co. KG |
|
|
11.13.1. Company Overview |
|
|
11.13.2. Products Offered |
|
|
11.13.3. Financials |
|
|
11.13.4. Recent Development |
|
|
11.14. Medi-Globe GmbH |
|
|
11.14.1. Company Overview |
|
|
11.14.2. Products Offered |
|
|
11.14.3. Financials |
|
|
11.14.4. Recent Development |
|
|
11.15. Medtronic, Plc |
|
|
11.15.1. Company Overview |
|
|
11.15.2. Products Offered |
|
|
11.15.3. Financials |
|
|
11.15.4. Recent Development |
|
|
11.16. Merit Medical Systems, Inc. |
|
|
11.16.1. Company Overview |
|
|
11.16.2. Products Offered |
|
|
11.16.3. Financials |
|
|
11.16.4. Recent Development |
|
|
11.17. Olympus Corporation |
|
|
11.17.1. Company Overview |
|
|
11.17.2. Products Offered |
|
|
11.17.3. Financials |
|
|
11.17.4. Recent Development |
|
|
11.18. Sonoscape Medical Corp. |
|
|
11.18.1. Company Overview |
|
|
11.18.2. Products Offered |
|
|
11.18.3. Financials |
|
|
11.18.4. Recent Development |
|
|
11.19. Steris Plc |
|
|
11.19.1. Company Overview |
|
|
11.19.2. Products Offered |
|
|
11.19.3. Financials |
|
|
11.19.4. Recent Development |
|
|
11.20. Taewoong Medical Co., Ltd. |
|
|
11.20.1. Company Overview |
|
|
11.20.2. Products Offered |
|
|
11.20.3. Financials |
|
|
11.20.4. Recent Development |
|
|
11.21. Telemed Systems, Inc. |
|
|
11.21.1. Company Overview |
|
|
11.21.2. Products Offered |
|
|
11.21.3. Financials |
|
|
11.21.4. Recent Development |
|
|
11.22. Telemed Systems, Inc. |
|
|
11.22.1. Company Overview |
|
|
11.22.2. Products Offered |
|
|
11.22.3. Financials |
|
|
11.22.4. Recent Development |
|
|
Chapter 12. Appendix |
|
|
12.1. Discussion guide |
|
|
12.2. Knowledge Store: Zettabyte Analytics
Subscription Portal |
|
|
12.3. Available Customizations |
|
|
12.4. Associated Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
1 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2021 & 2029) |
|
2 |
Endoscopes Market Estimates and Forecast,
2019-2029 (USD Million) |
|
3 |
Endoscopes Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
4 |
Endotherapy Devices Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
5 |
Endotherapy Devices Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
6 |
Energy Devices Market Estimates and Forecast,
2019-2029 (USD Million) |
|
7 |
Energy Devices Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
8 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
9 |
Biliary Dialtation Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
10 |
Biliary Dialtation Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
11 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
12 |
Ambulatory Surgery Centres & Clinics
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
13 |
Ambulatory Surgery Centres & Clinics
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
14 |
Hospitals Market Estimates and Forecast,
2019-2029 (USD Million) |
|
15 |
Hospitals Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
16 |
Other End Users Market Estimates and Forecast,
2019-2029 (USD Million) |
|
17 |
Other End Users Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
18 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
19 |
Ambu A/S Market Estimates and Forecast,
2019-2029 (USD Million) |
|
20 |
Ambu A/S Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
21 |
B. Braun Melsungen AG Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
22 |
B. Braun Melsungen AG Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
23 |
Boston Scientific Corporation Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
24 |
Boston Scientific Corporation Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
25 |
North America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
26 |
North America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
27 |
North America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
28 |
North America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
29 |
North America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Country, 2018-2029 (USD Million) |
|
30 |
U.S. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
31 |
U.S. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
32 |
U.S. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
33 |
U.S. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
34 |
Canada Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
35 |
Canada Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
36 |
Canada Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
37 |
Canada Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
38 |
Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
39 |
Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
40 |
Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
41 |
EuropeEndoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
42 |
Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Country, 2018-2029 (USD Million) |
|
43 |
Germany Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
44 |
Germany Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
45 |
Germany Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
46 |
Germany Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
47 |
U.K. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
48 |
U.K. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
49 |
U.K. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
50 |
U.K. Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
51 |
France Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
52 |
France Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
53 |
France Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
54 |
France Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
55 |
Spain Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
56 |
Spain Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
57 |
Spain Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
58 |
Spain Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
59 |
Italy Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
60 |
Italy Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
61 |
Italy Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
62 |
Italy Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
63 |
Rest of Europe Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
64 |
Rest of Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
65 |
Rest of Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
66 |
Rest of Europe Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
67 |
Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type, 2018-2029 (USD Million) |
|
68 |
Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
69 |
Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
70 |
Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
71 |
Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Country, 2018-2029 (USD Million) |
|
72 |
India Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
73 |
India Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
74 |
India Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
75 |
India Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
76 |
Japan Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
77 |
Japan Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
78 |
Japan Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User, 2018-2029 (USD Million) |
|
79 |
Japan Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
80 |
China Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
81 |
China Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
82 |
China Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
83 |
China Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
84 |
South Korea Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
85 |
South Korea Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
86 |
South Korea Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
87 |
South Korea Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company, 2018-2029 (USD Million) |
|
88 |
Australia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
89 |
Australia Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
90 |
Australia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
91 |
Australia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
92 |
Rest of Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
93 |
Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
94 |
Rest of Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
95 |
Rest of Asia Pacific Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
96 |
Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
97 |
Middle East & AfricaEndoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
98 |
Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
99 |
Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
100 |
Middle East & Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Country, 2018-2029 (USD Million) |
|
101 |
UAE Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
102 |
UAE Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
103 |
UAE Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
104 |
UAE Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
105 |
Saudi Arabia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
106 |
Saudi Arabia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
107 |
Saudi Arabia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
108 |
Saudi Arabia Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
109 |
South Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
110 |
South Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
111 |
South Africa Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
112 |
South Africa Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company, 2018-2029 (USD Million) |
|
113 |
Rest of Middle East & Africa Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029
(USD Million) |
|
114 |
Rest of Middle East & Africa Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029
(USD Million) |
|
115 |
Rest of Middle East & Africa Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, By End User, 2018-2029
(USD Million) |
|
116 |
Rest of Middle East & Africa Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD
Million) |
|
117 |
Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
118 |
Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
119 |
Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
120 |
Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company, 2018-2029 (USD Million) |
|
121 |
Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Country, 2018-2029 (USD Million) |
|
122 |
Brazil Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
123 |
Brazil Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
124 |
Brazil Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
125 |
Brazil Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
126 |
Mexico Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
127 |
Mexico Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
128 |
Mexico Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
129 |
Mexico Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company, 2018-2029 (USD Million) |
|
130 |
Argentina Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
131 |
Argentina Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
132 |
Argentina Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
133 |
Argentina Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Company, 2018-2029 (USD Million) |
|
134 |
Rest of Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Product Type, 2018-2029 (USD
Million) |
|
135 |
Rest of Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By Procedure, 2018-2029 (USD Million) |
|
136 |
Rest of Latin America Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market, By End User, 2018-2029 (USD Million) |
|
137 |
Rest of Latin America Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company, 2018-2029 (USD Million) |
|
138 |
Product Launch & Development in The
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, 2018-2021 |
|
139 |
Recent Development in The Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, 2018-2021 |
|
140 |
Partnership & Collaboration in The
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, 2018-2021 |
|
141 |
Merger & Acquisition in The Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market, 2018-2021 |
|
List of Figures |
|
|
1 |
Research Methodology |
|
2 |
Summary Snapshot Market Size and Forecast, USD
Million, 2021 & 2029 |
|
3 |
Global Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market Segmentation & Impact Analysis |
|
4 |
Regulatory Analysis |
|
5 |
COVID-19 Impact analysis on Endoscopic
Retrograde Cholangiopancreatography (ERCP) Market |
|
6 |
Market Revenue Share by Manufacturers |
|
7 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2021 & 2029) |
|
8 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Procedure (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
9 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By End User (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
10 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Company (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
11 |
Endoscopic Retrograde Cholangiopancreatography
(ERCP) Market, By Region (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States